Neovacs S.A. (ALNEV.PA)
EUR 1.11
(-11.15%)
EUR 1.11
(-11.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 533.41 Thousand | 1112.00 | 22.54 Thousand | 29.78 Thousand | 95.15 Thousand | 145 Thousand |
| Cost of Revenue | 504.09 Thousand | 3.43 Million | 3.54 Million | 1.82 Million | 56.2 Thousand | 9.49 Million |
| Gross Profit | 29.31 Thousand | -3.43 Million | -3.51 Million | -1.79 Million | 38.94 Thousand | -9.35 Million |
| Operating Expenses | 10.34 Million | 2.99 Million | 4.32 Million | 1.69 Million | 8.21 Million | 10.59 Million |
| Selling, General and Administrative Expenses | 5.87 Million | 382.12 Thousand | -45.83 Thousand | 434.49 Thousand | 2.41 Million | 3.49 Million |
| Research and Development Expenses | 4.47 Million | 2.5 Million | 4.22 Million | 1.19 Million | 5.86 Million | 10.59 Million |
| Other Expenses | - | -112.49 Thousand | -147.32 Thousand | -65.89 Thousand | 70.18 Thousand | - |
| Cost and Expenses | 7.44 Million | 6.43 Million | 7.86 Million | 3.52 Million | 8.26 Million | 13.41 Million |
| Operating Income | -6.9 Million | -6.42 Million | -7.83 Million | -3.49 Million | -8.26 Million | -13.08 Million |
| Interest Expense | 856.74 Thousand | 586.08 Thousand | 2 Million | 2 Million | 106.88 Thousand | 473 Thousand |
| Income Tax Expense | -876.75 Thousand | -797.43 Thousand | -641.04 Thousand | -541.5 Thousand | -1.75 Million | -2.77 Million |
| Earnings before Tax | -9.62 Million | -4.34 Million | -12.47 Million | -6.68 Million | -9.3 Million | -13.55 Million |
| Net Income | -8.74 Million | -3.54 Million | -11.83 Million | -6.14 Million | -7.54 Million | -10.78 Million |
| Earnings Per Share Basic | -0.00 | -117.60 | -47.56 Thousand | -729.37 Thousand | -3.83 Million | -10.78 Million |
| Earnings Per Share Diluted | -0.00 | -117.60 | -47.56 Thousand | -729.37 Thousand | -3.83 Million | -10.78 Million |
| Weighted Average Shares Outstanding | 3.51 Billion | 30.17 Thousand | 248.86 | 8.42 | 1.97 | 1.00 |
| Weighted Average Shares Outstanding (Diluted) | 3.51 Billion | 30.17 Thousand | 248.86 | 8.42 | 1.97 | 1.00 |
| Gross Margin | 0.05 | -3088.66 | -156.04 | -60.26 | 0.41 | -64.49 |
| EBIT Margin | -15.84 | -5645.74 | -343.37 | -115.42 | -86.32 | -89.76 |
| Profit Margin | -16.39 | -3191.10 | -525.12 | -206.24 | -79.33 | -74.34 |
| EBITDA | -8.44 Million | -3.6 Million | -10.37 Million | -4.62 Million | -9.13 Million | -13.08 Million |
| Earnings Before Tax Margin | -12.95 | -5781.80 | -347.77 | -117.27 | -86.91 | -90.21 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 250.26 Thousand | 533.41 Thousand | 431.04 Thousand | 102.37 Thousand | 1112.00 | -48.88 Thousand |
| Cost of Revenue | 3.36 Million | 7.28 Million | 2 Million | 3.71 Million | 3.43 Million | 1.63 Million |
| Gross Profit | -3.11 Million | -6.75 Million | -1.56 Million | -3.61 Million | -3.43 Million | -1.68 Million |
| Operating Expenses | 592.92 Thousand | 153.19 Thousand | 7.21 Million | 68.43 Thousand | 2.99 Million | 2.35 Million |
| Selling, General and Administrative Expenses | 26.75 Thousand | - | 1.48 Million | 24.03 Thousand | - | 942.27 Thousand |
| Research and Development Expenses | - | - | 4.47 Million | - | - | 4.05 Million |
| Other Expenses | -566.17 Thousand | -105.25 Thousand | -60.85 Thousand | -44.4 Thousand | -112.49 Thousand | - |
| Cost and Expenses | 3.95 Million | 7.44 Million | 9.21 Million | 3.78 Million | 6.43 Million | 3.99 Million |
| Operating Income | -3.7 Million | -6.9 Million | -3.22 Million | -3.67 Million | -6.42 Million | -2.8 Million |
| Interest Expense | - | 1 Million | - | 1.22 Million | 586.08 Thousand | - |
| Income Tax Expense | -451.32 Thousand | -876.75 Thousand | 575.19 Thousand | -301.56 Thousand | -797.43 Thousand | 376.72 Thousand |
| Earnings before Tax | -31.44 Million | -9.62 Million | -5.03 Million | -4.58 Million | -4.34 Million | -1.09 Million |
| Net Income | -30.99 Million | -8.74 Million | -4.46 Million | -4.28 Million | -3.54 Million | -714.18 Thousand |
| Earnings Per Share Basic | -3.32 | - | -0.00 | -3.06 | - | - |
| Earnings Per Share Diluted | -3.32 | - | -0.00 | -3.06 | - | - |
| Weighted Average Shares Outstanding | 9.33 Million | 3.51 Billion | 3.51 Billion | 1.39 Million | 30.17 Thousand | - |
| Weighted Average Shares Outstanding (Diluted) | 9.33 Million | 3.51 Billion | 3.51 Billion | 1.39 Million | 30.17 Thousand | - |
| Gross Margin | -12.45 | -12.66 | -3.64 | -35.27 | -3088.66 | 34.48 |
| EBIT Margin | -125.25 | - | -5.70 | -35.17 | - | 55.81 |
| Profit Margin | -123.83 | -16.39 | -10.35 | -41.84 | -3191.10 | 14.61 |
| EBITDA | -31.34 Million | - | -2.45 Million | -3.6 Million | - | -2.72 Million |
| Earnings Before Tax Margin | -14.81 | -12.95 | -7.49 | -35.94 | -5781.80 | 57.40 |
DIM
TRICOMFRU
ACTG
CUBI-PE
SNLK
33637L